Literature DB >> 6253

The kidney and antihypertensive therapy.

R R Bailey.   

Abstract

Renal disease and hypertension is a continuing challenge to the nephrologist. At present there are few effective methods of dealing with the common renal diseases such as glomerulonephritis, but fortunately there is now a wide selection of potent antihypertensive agents. Drug resistant hypertension should be a rarity in clinical practice. Malignant hypertension remains a therapeutic emergency. If a patient with hypertension has renal functional impairment it is essential to lower the blood pressure to normal. In the presence of renal failure this should be done with caution so as to avoid a further deterioration in the glomerular filtration rate. However, if the blood pressure is controlled and especially if the renal failure is a result of hypertension alone, renal function may stabilise or even improve, often dramatically.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6253     DOI: 10.2165/00003495-197600111-00019

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  15 in total

1.  Side effects due to treatment of hypertension with prazosin.

Authors:  M J Bendall; K H Baloch; P R Wilson
Journal:  Br Med J       Date:  1975-06-28

2.  Letter: Clonidine (Catapres) overshoot.

Authors:  R R Bailey
Journal:  N Z Med J       Date:  1975-03-12

3.  Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease.

Authors:  E Shinebourne; J Fleming; J Hamer
Journal:  Lancet       Date:  1967-12-09       Impact factor: 79.321

4.  Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.

Authors:  H Ibsen; P Sederberg-Olsen
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

5.  Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension.

Authors:  D J Warren; C P Swainson; N Wright
Journal:  Br Med J       Date:  1974-04-27

6.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

7.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

8.  Pharmacodynamics of practolol in chronic renal failure.

Authors:  J B Eastwood; J R Curtis; R B Smith
Journal:  Br Med J       Date:  1973-11-10

9.  [Comparative study of the influence of beta-adrenergic stimulants and adrenergic blocking drugs on renal function in normal humans].

Authors:  G Bufano; L Piacentini
Journal:  Minerva Med       Date:  1969-04-04       Impact factor: 4.806

10.  Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields.

Authors:  W G Nayler; I McInnes; J B Swann; V Carson; T E Lowe
Journal:  Am Heart J       Date:  1967-02       Impact factor: 4.749

View more
  4 in total

Review 1.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

2.  Labetalol in the treatment of patients with hypertension and renal function impairment.

Authors:  R R Bailey
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Labetolol in patients with hypertension and varying degrees of renal impairment.

Authors:  E G Breen; M Lombard; A Watson; J A Keogh
Journal:  Ir J Med Sci       Date:  1984-10       Impact factor: 1.568

4.  Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator.

Authors:  E G Breen; D Mulhall; J A Keogh
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.